Drugs by condition
Drugs approved for crohn's disease
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
0
Still marketed, NDA or BLA
Drug classes
0
Novel drugs
0
New molecular entities and new biologics
In development
22
Investigational drugs in Phase 2 or 3
All approved drugs for crohn's disease, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
No current brand-name label names this in its indications. Try another name for the condition, or a broader term.
Drugs in development for crohn's disease
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- ZasocitinibTAK- 279, NDI-034858Phase 317 trials
Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease
- AfimkibartRO7790121, RVT-3101Phase 312 trials
Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis
- MK-7240PRA023, TulisokibartPhase 310 trials
Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease
- hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials
Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)
- LutikizumabABT-981Phase 38 trials
AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis
- DuvakitugSAR447189, TEV-48574 APhase 36 trials
Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis
- ABX464ObefazimodPhase 35 trials
Abivax S.A. · Ulcerative Colitis, Moderately to Severely Active Crohn Disease
- JNJ-78934804JNJ-4804Phase 34 trials
Johnson & Johnson (Janssen) · Colitis, Ulcerative, Crohn's Disease, Crohn Disease
- brivekimigSAR442970Phase 25 trials
Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus
- MORF-057zotemtegrast, LY4268989Phase 24 trials
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)
- ABBV-701Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis
- AGMB-129OntunisertibPhase 22 trials
Agomab Spain S.L.U. · Fibrostenotic Crohn's Disease
- anti-TL1A monoclonal antibodyPhase 22 trials
Biocad · Ulcerative Colitis (UC), Crohn's Disease (CD)
- AZD7798Phase 22 trials
AstraZeneca · Moderate to Severe Crohn's Disease, Crohn's Disease
- DB-3QPhase 22 trials
Direct Biologics, LLC · Perianal Fistula Due to Crohn's Disease, Crohn Disease (CD)
- LY4395089Phase 22 trials
Eli Lilly · Crohn Disease, Colitis, Ulcerative
- SL-325Phase 22 trials
Shattuck Labs, Inc. · Crohn's Disease, Hidradenitis Suppurativa (HS)
- TrosunilimabABBV-382Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis
- ABBV-8736Phase 21 trial
AbbVie · Crohn's Disease
- MT-201Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
More on crohn's disease: recruiting trials · published research
Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria) · Alopecia areata
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.